Variant report
Variant | esv3396642 |
---|---|
Chromosome Location | chr5:1972288-1972498 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1967228..1969349-chr5:1970170..1972836,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248597 | chromatin interactions |
ENSG00000249731 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145966533 | chr5:1972293-1972294 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs138929209 | chr5:1972294-1972295 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs549353184 | chr5:1972304-1972305 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs571651022 | chr5:1972317-1972318 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs538963285 | chr5:1972318-1972319 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs376465060 | chr5:1972319-1972320 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs79629799 | chr5:1972357-1972358 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs36019023 | chr5:1972374-1972375 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs181427088 | chr5:1972375-1972376 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs555126407 | chr5:1972377-1972378 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs113902051 | chr5:1972385-1972386 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs112132152 | chr5:1972386-1972387 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs62337128 | chr5:1972391-1972392 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs62337129 | chr5:1972394-1972395 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs62337130 | chr5:1972397-1972398 | Weak transcription Enhancers Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs62337131 | chr5:1972408-1972409 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs62337132 | chr5:1972411-1972412 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs113444106 | chr5:1972414-1972415 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs62337133 | chr5:1972425-1972426 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs187505161 | chr5:1972428-1972429 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs191806554 | chr5:1972431-1972432 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs111846149 | chr5:1972437-1972438 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs368757184 | chr5:1972442-1972443 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs537482628 | chr5:1972443-1972444 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs558988500 | chr5:1972444-1972445 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs577121016 | chr5:1972445-1972446 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs62337134 | chr5:1972454-1972455 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs186034176 | chr5:1972459-1972460 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs373703118 | chr5:1972471-1972472 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs367575615 | chr5:1972493-1972494 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs371374833 | chr5:1972496-1972497 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1964000-1972800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:1967000-1973400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr5:1967000-1973800 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr5:1968000-1973600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr5:1968400-1972600 | Weak transcription | HMEC | breast |
6 | chr5:1971000-1972800 | Weak transcription | Esophagus | oesophagus |
7 | chr5:1971600-1972400 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr5:1971600-1973800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr5:1971800-1972400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |